Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Sep;70(3):526–535. doi: 10.1172/JCI110644

Binding of human factor VII and VIIa to monocytes.

G J Broze Jr
PMCID: PMC370253  PMID: 6980899

Abstract

Human coagulation Factors VII and VIIa bind with equal affinity to monocytes stimulated with endotoxin. Equilibrium binding studies performed at 0 degrees C using 125I-labeled Factor VII and VIIa showed the dissociation constant (Kd) to be congruent to 82 pM with congruent to 3,600 binding sites/monocyte. Ca++ was required for Factor VII and VIIa interaction with monocytes (optimal CaC12 concentration greater than or equal to 2.5 mM) and binding was reversed by the addition of EDTA. The rate of conversion of Factor X to Xa in mixtures containing Factor VIIa and monocytes was directly related to the quantity of Factor VIIa bound to the monocyte surface. Thus the monocyte binding sites appear to represent tissue factor. Competition experiments showed that Factor VII and VIIa bind to the same monocyte sites and further, that unlabeled Factor VII and VIIa have the same affinity for the binding sites as the 125I-labeled proteins.

Full text

PDF
526

Images in this article

528Image
on p.528
529Image
on p.529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babul J., Stellwagen E. Measurement of protein concentration with interferences optics. Anal Biochem. 1969 Apr 4;28(1):216–221. doi: 10.1016/0003-2697(69)90172-9. [DOI] [PubMed] [Google Scholar]
  2. Bajaj S. P., Rapaport S. I., Brown S. F. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem. 1981 Jan 10;256(1):253–259. [PubMed] [Google Scholar]
  3. Blatt P. M., Lundblad R. L., Kingdon H. S., McLean G., Roberts H. R. Thrombogenic materials in prothrombin complex concentrates. Ann Intern Med. 1974 Dec;81(6):766–770. doi: 10.7326/0003-4819-81-6-766. [DOI] [PubMed] [Google Scholar]
  4. Broze G. J., Jr, Majerus P. W. Purification and properties of human coagulation factor VII. J Biol Chem. 1980 Feb 25;255(4):1242–1247. [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Cederbaum A. I., Blatt P. M., Roberts H. R. Intravascular coagulation with use of human prothrombin complex concentrates. Ann Intern Med. 1976 Jun;84(6):683–687. doi: 10.7326/0003-4819-84-6-683. [DOI] [PubMed] [Google Scholar]
  7. Davey R. J., Shashaty G. G., Rath C. E. Acute coagulopathy following infusion of prothrombin complex concentrate. Am J Med. 1976 May 10;60(5):719–722. doi: 10.1016/0002-9343(76)90509-x. [DOI] [PubMed] [Google Scholar]
  8. Edwards R. L., Rickles F. R., Bobrove A. M. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood. 1979 Aug;54(2):359–370. [PubMed] [Google Scholar]
  9. Edwards R. L., Rickles F. R. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol. 1980 Aug;125(2):606–609. [PubMed] [Google Scholar]
  10. Faraci P. A., Deterling R. A., Jr, Stein A. M., Rheinlander H. F., Cleveland R. J. Warfarin induced necrosis of the skin. Surg Gynecol Obstet. 1978 May;146(5):695–700. [PubMed] [Google Scholar]
  11. Fogelman A. M., Seager J., Edwards P. A., Hokom M., Popják G. Cholesterol biosynthesis in human lymphocytes, monocytes, and granulocytes. Biochem Biophys Res Commun. 1977 May 9;76(1):167–173. doi: 10.1016/0006-291x(77)91682-5. [DOI] [PubMed] [Google Scholar]
  12. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  13. GODAL H. C., MADSEN K., MEYER R. N. Thrombo-embolism in patients with total proconvertin (factor VII) deficency. A report on two cases. Acta Med Scand. 1962 Mar;171:325–327. [PubMed] [Google Scholar]
  14. Gershwin M. E., Gude J. K. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med. 1973 Jan 18;288(3):141–142. doi: 10.1056/NEJM197301182880309. [DOI] [PubMed] [Google Scholar]
  15. HALL C. A., RAPAPORT S. I., AMES S. B., DEGROOT J. A. A CLINICAL AND FAMILY STUDY OF HEREDITARY PROCONVERTIN (FACTOR VII) DEFICIENCY. Am J Med. 1964 Aug;37:172–181. doi: 10.1016/0002-9343(64)90003-8. [DOI] [PubMed] [Google Scholar]
  16. Josso F., Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh Suppl. 1965;17:35–44. [PubMed] [Google Scholar]
  17. Kasper C. K. Postoperative thromboses in hemophilia B. N Engl J Med. 1973 Jul 19;289(3):160–160. doi: 10.1056/NEJM197307192890321. [DOI] [PubMed] [Google Scholar]
  18. Kasper C. K. Thromboembolic complications. Thromb Diath Haemorrh. 1975 Jun 30;33(3):640–644. [PubMed] [Google Scholar]
  19. Kisiel W., Fujikawa K., Davie E. W. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Biochemistry. 1977 Sep 20;16(19):4189–4194. doi: 10.1021/bi00638a009. [DOI] [PubMed] [Google Scholar]
  20. Koch-Weser J. Coumarin necrosis. Ann Intern Med. 1968 Jun;68(6):1365–1367. doi: 10.7326/0003-4819-68-6-1365. [DOI] [PubMed] [Google Scholar]
  21. Laake K., Osterud B. Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system. Thromb Res. 1974 Dec;5(6):759–772. doi: 10.1016/0049-3848(74)90119-4. [DOI] [PubMed] [Google Scholar]
  22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  23. Lerner R. G., Goldstein R., Cummings G., Lange K. Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med. 1971 Oct;138(1):145–148. doi: 10.3181/00379727-138-35848. [DOI] [PubMed] [Google Scholar]
  24. Letter: Prothrombin-complex concentrates and thrombosis. N Engl J Med. 1974 Feb 14;290(7):403–404. doi: 10.1056/NEJM197402142900718. [DOI] [PubMed] [Google Scholar]
  25. Letter: Prothrombin-complex concentrates and thrombosis. N Engl J Med. 1974 Feb 14;290(7):403–404. doi: 10.1056/NEJM197402142900718. [DOI] [PubMed] [Google Scholar]
  26. Levy G. A., Edgington T. S. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med. 1980 May 1;151(5):1232–1244. doi: 10.1084/jem.151.5.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Levy G. A., Schwartz B. S., Curtiss L. K., Edgington T. S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. J Clin Invest. 1981 Jun;67(6):1614–1622. doi: 10.1172/JCI110196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Marlar R. A., Griffin J. H. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma. Ann N Y Acad Sci. 1981;370:325–335. doi: 10.1111/j.1749-6632.1981.tb29745.x. [DOI] [PubMed] [Google Scholar]
  29. Maynard J. R., Dreyer B. E., Stemerman M. B., Pitlick F. A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood. 1977 Sep;50(3):387–396. [PubMed] [Google Scholar]
  30. Maynard J. R., Heckman C. A., Pitlick F. A., Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975 Apr;55(4):814–824. doi: 10.1172/JCI107992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Miletich J. P., Broze G. J., Jr, Majerus P. W. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem. 1980 Jul 1;105(2):304–310. doi: 10.1016/0003-2697(80)90462-5. [DOI] [PubMed] [Google Scholar]
  32. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J Biol Chem. 1978 Oct 10;253(19):6908–6916. [PubMed] [Google Scholar]
  33. Muhlfelder T. W., Khan I., Niemetz J. Factors influencing the release of procoagulant-tissue factor activity from leukocytes. J Lab Clin Med. 1978 Jul;92(1):65–72. [PubMed] [Google Scholar]
  34. Muhlfelder T. W., Niemetz J., Kreutzer D., Beebe D., Ward P. A., Rosenfeld S. I. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest. 1979 Jan;63(1):147–150. doi: 10.1172/JCI109269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nemerson Y., Esnouf M. P. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor. Proc Natl Acad Sci U S A. 1973 Feb;70(2):310–314. doi: 10.1073/pnas.70.2.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry. 1966 Feb;5(2):601–608. doi: 10.1021/bi00866a029. [DOI] [PubMed] [Google Scholar]
  37. Niemetz J., Marcus A. J. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest. 1974 Dec;54(6):1437–1443. doi: 10.1172/JCI107891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Norris D. A., Morris R. M., Sanderson R. J., Kohler P. F. Isolation of functional subsets of human peripheral blood monocytes. J Immunol. 1979 Jul;123(1):166–172. [PubMed] [Google Scholar]
  39. Osterud B., Bögwald J., Lindahl U., Seljelid R. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett. 1981 May 5;127(1):154–160. doi: 10.1016/0014-5793(81)80363-8. [DOI] [PubMed] [Google Scholar]
  40. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Radcliffe R., Bagdasarian A., Colman R., Nemerson Y. Activation of bovine factor VII by hageman factor fragments. Blood. 1977 Oct;50(4):611–617. [PubMed] [Google Scholar]
  42. Radcliffe R., Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975 Jan 25;250(2):388–395. [PubMed] [Google Scholar]
  43. Radcliffe R., Nemerson Y. Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J Biol Chem. 1976 Aug 25;251(16):4749–4802. [PubMed] [Google Scholar]
  44. Rivers R. P., Hathaway W. E., Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 1975 Jul;30(3):311–316. doi: 10.1111/j.1365-2141.1975.tb00547.x. [DOI] [PubMed] [Google Scholar]
  45. Rothberger H., Zimmerman T. S., Spiegelberg H. L., Vaughan J. H. Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest. 1977 Mar;59(3):549–557. doi: 10.1172/JCI108670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sanderson R. J., Shepperdson R. T., Vatter A. E., Talmage D. W. Isolation and enumeration of peripheral blood monocytes. J Immunol. 1977 Apr;118(4):1409–1414. [PubMed] [Google Scholar]
  47. Schimpf K., Zimmermann K., Kömpf B. DIC and postoperative wound bleeding under factor IX. Substitution therapy in a case of hemophilia B; sucessful treatment with heparin. Thromb Res. 1976 Jan;8(1):65–70. doi: 10.1016/0049-3848(76)90124-9. [DOI] [PubMed] [Google Scholar]
  48. Seligsohn U., Kasper C. K., Osterud B., Rapaport S. I. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood. 1979 May;53(5):828–837. [PubMed] [Google Scholar]
  49. Seligsohn U., Osterud B., Brown S. F., Griffin J. H., Rapaport S. I. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest. 1979 Oct;64(4):1056–1065. doi: 10.1172/JCI109543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tullis J. L., Melin M., Jurigian P. Clinical use of human prothrombin complexes. N Engl J Med. 1965 Sep 23;273(13):667–674. doi: 10.1056/NEJM196509232731301. [DOI] [PubMed] [Google Scholar]
  51. Weston W. L., Dustin R. D., Hecht S. K. Quantitative assays of human monocyte-macrophage function. J Immunol Methods. 1975 Sep;8(3):213–222. doi: 10.1016/0022-1759(75)90114-3. [DOI] [PubMed] [Google Scholar]
  52. Zacharski L. R., McIntyre O. R. Characterization of procoagulants produced in cell cultures by tests of coagulation. Thromb Diath Haemorrh. 1971 Dec 31;26(3):493–502. [PubMed] [Google Scholar]
  53. Zacharski L. R., McIntyre O. R. Membrane-mediated synthesis of tissue factor (thromboplastin) in cultured fibroblasts. Blood. 1973 May;41(5):679–685. [PubMed] [Google Scholar]
  54. Zur M., Nemerson Y. The esterase activity of coagulation factor VII. Evidence for intrinsic activity of the zymogen. J Biol Chem. 1978 Apr 10;253(7):2203–2209. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES